Picture of Zentiva SA logo

SCD Zentiva SA Share Price

0.000.00%
ro flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Momentum

Relative Strength (%)
1m-6.86%
3m+16.83%
6m+26.61%
1yr+52.29%
Volume Change (%)
10d/3m-28.5%
Price vs... (%)
52w High-12.17%
50d MA-4.42%
200d MA+17.5%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value2.11
Price to Tang. Book2.16
Price to Free Cashflow71.61
Price to Sales2.67
EV to EBITDA7.41

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital19.4%
Return on Equity21.89%
Operating Margin25.03%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueRONm559.01557.96710.93759.63953.63n/an/a15.63%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-79.48+28.37+59.88-6.08+88.82n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Zentiva SA EPS forecast chart

Profile Summary

Zentiva SA is a Romania-based company engaged in the pharmaceutical industry. The Company is primarily engaged in the production and commercialization of pharmaceutical preparations. The Company’s portfolio includes approximately 280 products and drugs for cardiovascular, nervous and digestive systems; pain treatment, and urological and anti-inflammatory diseases, among others. Additionally, the Company is active in the production of dietary supplements and vitamins. It has production sites in Czech Republic, Slovakia, Romania and Turkey. As of December 31, 2011, Venoma Holdings Limited held a 50.98% stake in Zentiva SA. The Company had one wholly owned subsidiary, Pallady Business Park SRL, as of December 31, 2011.

Directors

Last Annual
December 31st, 2023
Last Interim
June 30th, 2024
Incorporated
February 9th, 1991
Public Since
August 13th, 1998
No. of Employees
1,035
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
ro flag iconBucharest Stock Exchange
Shares in Issue
697,017,040

SCD Share Price Performance

Upcoming Events for SCD

Similar to SCD

Picture of Antibiotice SA logo

Antibiotice SA

ro flag iconBucharest Stock Exchange

Picture of Biofarm SA logo

Biofarm SA

ro flag iconBucharest Stock Exchange

FAQ